Recent Trends of AI in Pharmaceutical Industries: A Review
Received Date: Apr 01, 2024 / Published Date: Apr 29, 2024
Abstract
Artificial intelligence (AI) algorithms have been used to evaluate actual knowledge, reports on unfavorable occurrences, and publications to monitor post-marketing medication safety and detect possible safety concerns concerning security and respect to standards. AI has also been helpful in signal verification, adverse event prediction, and pharmacovigilance. AI is additionally implemented in streamlining pharmaceutical supply chains, guaranteeing effective distribution, management of inventory, and output. The possibilities of AI in PKPD studies are being recognized by pharmaceutical firms more and more. AI includes significant tools and techniques that help improve the processes involved in medication development and discovery. GNS Medical Care, AstraZeneca, Atomwise, Recursion Pharmaceuticals, and Insilico Medicines are a few instances. AI has been useful in the advancement of strategies for the rapid and perfect manufacture of dosage forms.
AI possesses the possibility to completely overhaul the medical industry in the future by driving up the process of medication creation and discovery. With the use of virtual screening techniques, large chemical libraries will be effectively assessed to determine therapeutic candidates with the necessary lead compound identification time. By reviewing genomes, proteomes, and health data, AI-enabled precision nursing may be able to divide up patients, determine the results of treatment, and personalize medications. Using generative models and deep learning, scientists can produce novel molecules with target-binding properties that increase drug efficacy and decrease side effects. AI will also enable dosage formulations tailored to individual patients. AI algorithms will improve drug formulations as well as delivery systems for improving health service outcomes by accounting for factors unique to each patient, such as size, age, heritage, and medical condition disease. Security evaluations he transform as a result of AI algorithms' ability to predict the toxicity and potential negative effects of medications.
Citation: Rutuja N (2024) Recent Trends of AI in Pharmaceutical Industries: AReview. Int J Res Dev Pharm L Sci, 10: 206. Doi: 10.4172/2278-0238.1000206
Copyright: © 2024 Rutuja N. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 572
- [From(publication date): 0-2024 - Mar 10, 2025]
- Breakdown by view type
- HTML page views: 519
- PDF downloads: 53